Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Warby Parker (WRBY)
NYSE:WRBY
Warby Parker (WRBY) Stock Price & Analysis
49 Followers
WRBY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.50 - $18.99
Previous Close$12.21
Volume946.39K
Average Volume (3M)1.10M
Market Cap
$1.41B
Enterprise Value$1.38B
Total Cash (Recent Filing)$204.26M
Total Debt (Recent Filing)$170.63M
Price to Earnings (P/E)-16.2
Beta2.30
Next Earnings
Aug 10, 2023EPS Estimate
$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.76
Shares Outstanding116,133,679
10 Day Avg. Volume880,318
30 Day Avg. Volume1,100,306
Standard Deviation0.17
R-Squared0.43
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)5.19
Price to Sales (P/S)6.85
Price to Cash Flow (P/CF)36.80
P/FCF Ratio36.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.24
Enterprise Value/Gross Profit4.05
Enterprise Value/Ebitda-24.80
Forecast
1Y Price Target
$15.43Price Target Upside26.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Warby Parker News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
The estimated number of people who visited one or more of the websites owned by Warby Parker
Desktop Users
Mobile Users
WRBY FAQ
What was Warby Parker’s price range in the past 12 months?
Warby Parker lowest stock price was $9.50 and its highest was $18.99 in the past 12 months.
What is Warby Parker’s market cap?
Currently, no data Available
When is Warby Parker’s upcoming earnings report date?
Warby Parker’s upcoming earnings report date is Aug 10, 2023 which is in 67 days.
How were Warby Parker’s earnings last quarter?
Warby Parker released its earnings results on May 09, 2023. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.045 by $0.015.
Is Warby Parker overvalued?
According to Wall Street analysts Warby Parker’s price is currently Undervalued.
Does Warby Parker pay dividends?
Warby Parker does not currently pay dividends.
What is Warby Parker’s EPS estimate?
Warby Parker’s EPS estimate is $0.02.
How many shares outstanding does Warby Parker have?
Warby Parker has 96,434,654 shares outstanding.
What happened to Warby Parker’s price movement after its last earnings report?
Warby Parker reported an EPS of $0.06 in its last earnings report, beating expectations of $0.045. Following the earnings report the stock price went up 0.331%.
Which hedge fund is a major shareholder of Warby Parker?
Among the largest hedge funds holding Warby Parker’s share is D1 Capital Partners LP. It holds Warby Parker’s shares valued at 158M.
---
Warby Parker Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.43 (26.37% Upside)
$15.43 (26.37% Upside)
Blogger Sentiment
Bullish
WRBY Sentiment 71%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 536.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $227.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 2.7%
Last 30 Days ▼ 2.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.09%
12-Months-Change
Fundamentals
Return on Equity
-30.17%
Trailing 12-Months
Asset Growth
2.43%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Warby Parker
Warby Parker Inc is engaged in designing and development of designer prescription glasses and contacts to eye exams and vision tests.
---
Top 5 ETFs holding WRBY
Vanguard Total Stock Market ETF
$26.38M
Fidelity Blue Chip Growth ETF
$790.18K
iShares Core S&P Total U.S. Stock Market ETF
$633.27K
Schwab U.S. Broad Market ETF
$361.11K
iShares Russell 3000 ETF
$281.93K
Up to five ETFs with an Outperform Smart Score that hold WRBY. The ETFs are listed according to market value of WRBY within the ETF
---
National Vision Holdings
―
Leslie's
―
Petco Health and Wellness Company
―
Taxus Pharmaceuticals Holdings
―
ODP
―
---